Bruno A. Benítez

10.8k total citations
67 papers, 2.4k citations indexed

About

Bruno A. Benítez is a scholar working on Physiology, Neurology and Molecular Biology. According to data from OpenAlex, Bruno A. Benítez has authored 67 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Physiology, 27 papers in Neurology and 24 papers in Molecular Biology. Recurrent topics in Bruno A. Benítez's work include Alzheimer's disease research and treatments (21 papers), Parkinson's Disease Mechanisms and Treatments (20 papers) and Neuroinflammation and Neurodegeneration Mechanisms (20 papers). Bruno A. Benítez is often cited by papers focused on Alzheimer's disease research and treatments (21 papers), Parkinson's Disease Mechanisms and Treatments (20 papers) and Neuroinflammation and Neurodegeneration Mechanisms (20 papers). Bruno A. Benítez collaborates with scholars based in United States, Spain and Colombia. Bruno A. Benítez's co-authors include Carlos Cruchaga, Breanna Cooper, Alison Goate, Oscar Harari, Sheng Chih Jin, Albert A. Davis, Pau Pástor, David M. Holtzman, Humberto Arboleda and Joel S. Perlmutter and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Bruno A. Benítez

62 papers receiving 2.4k citations

Peers

Countries citing papers authored by Bruno A. Benítez

Since Specialization

Citations

This map shows the geographic impact of Bruno A. Benítez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruno A. Benítez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruno A. Benítez more than expected).

Fields of papers citing papers by Bruno A. Benítez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruno A. Benítez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruno A. Benítez. The network helps show where Bruno A. Benítez may publish in the future.

Co-authorship network of co-authors of Bruno A. Benítez

This figure shows the co-authorship network connecting the top 25 collaborators of Bruno A. Benítez. A scholar is included among the top collaborators of Bruno A. Benítez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruno A. Benítez. Bruno A. Benítez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	880 MOLECULAR MARKERS ASSOCIATED WITH SELF-REPORTED PROGRESSIVE GUT DYSFUNCTION IN PARKINSON'S DISEASE PATIENTS 2024 ·Gastroenterology ·(unknown), Subhash Kulkarni, Bruno A. Benítez	1
2	Uncovering the role of cerebrovascular phenotypes in AD through deep multi‐omic molecular profiling of human brains 2024 ·Alzheimer s & Dementia ·Ricardo D’Oliveira Albanus, Ekaterina Aladyeva, Taylor Bertucci, Logan Brase, (unknown), Bruno A. Benítez, Greg T. Sutherland, Celeste M. Karch, Sally Temple, Oscar Harari	0
3	circRNAs mediate the effect of chronic lysosomal dysfunction on Alzheimer’s disease pathology 2023 ·Alzheimer s & Dementia ·(unknown), Abdallah M. Eteleeb, Niko-Petteri Nykänen, (unknown), (unknown), Oscar Harari, John R. Cirrito, Mark S. Sands, Bruno A. Benítez	1
4	An astrocyte BMAL1-BAG3 axis protects against alpha-synuclein and tau pathology 2023 ·Neuron ·Patrick W. Sheehan, Collin J. Nadarajah, (unknown), (unknown), Brenna C. Novotny, (unknown), Melvin W. King, Logan Brase, (unknown), Carla M. Yuede, (unknown), Tirth K. Patel, Oscar Harari, Bruno A. Benítez, Albert A. Davis, Erik S. Musiek	50
5	Integration of cerebrospinal fluid proteomics and clinical scaled scores for subtyping sporadic Parkinson’s disease 2023 ·Alzheimer s & Dementia ·(unknown), (unknown), Bruno A. Benítez	1
6	Defective proteostasis in induced pluripotent stem cell models of frontotemporal lobar degeneration 2022 ·Translational Psychiatry ·Sidhartha Mahali, Rita Martinez, Melvin W. King, (unknown), Oscar Harari, Bruno A. Benítez, Kanta Horie, Chihiro Sato, Sally Temple, Celeste M. Karch	11
7	Exome sequencing revealed PDE11A as a novel candidate gene for early-onset Alzheimer’s disease 2021 ·Human Molecular Genetics ·Wei Qin, Aihong Zhou, Xiumei Zuo, Longfei Jia, Fangyu Li, Qi Wang, Ying Li, Yiping Wei, Hongmei Jin, Carlos Cruchaga, Bruno A. Benítez, Jianping Jia	10
8	Overexpressing low-density lipoprotein receptor reduces tau-associated neurodegeneration in relation to apoE-linked mechanisms 2021 ·Neuron ·Yang Shi, Prabhakar S. Andhey, Christina Ising, (unknown), (unknown), Kevin Boyer, (unknown), Kaoru Yamada, Wei Qin, Melissa Manis, Javier Remolina Serrano, Bruno A. Benítez, Robert E. Schmidt, Maxim N. Artyomov, Jason D. Ulrich, David M. Holtzman	84
9	APOE genotype regulates pathology and disease progression in synucleinopathy 2020 ·Science Translational Medicine ·Albert A. Davis, (unknown), (unknown), Umber Dube, (unknown), (unknown), (unknown), Dhruva D. Dhavale, Rebecca L. Miller, (unknown), Patrick M. Sullivan, Carlos Cruchaga, Joel S. Perlmutter, Jason D. Ulrich, Bruno A. Benítez, Paul T. Kotzbauer, David M. Holtzman	116
10	TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis 2020 ·Acta Neuropathologica ·Francesca Cignarella, Fabia Filipello, Bryan Bollman, Claudia Cantoni, (unknown), Robert Mikesell, Melissa Manis, Adiljan Ibrahim, Li Deng, Bruno A. Benítez, Carlos Cruchaga, Danilo Licastro, Kathie A. Mihindukulasuriya, Oscar Harari, Michael E. Buckland, David M. Holtzman, Arnon Rosenthal, Tina Schwabe, Ilaria Tassi, Laura Piccio	257
11	Genetic ablation of acid ceramidase in Krabbe disease confirms the psychosine hypothesis and identifies a new therapeutic target 2019 ·Proceedings of the National Academy of Sciences ·Yedda Li, Yue Xu, Bruno A. Benítez, (unknown), Joshua T. Dearborn, Xuntian Jiang, Miguel A. Guzmán, Josh C. Woloszynek, (unknown), Bryan K. Yip, (unknown), Michael Babcock, (unknown), Stephen C. Fowler, David F. Wozniak, Carole Vogler, Jeffrey A. Medin, Brett E. Crawford, Mark S. Sands	75
12	Pooled-DNA target sequencing of Parkinson genes reveals novel phenotypic associations in Spanish population 2018 ·Neurobiology of Aging ·Mónica Díez-Fairén, Bruno A. Benítez, Sara Ortega‐Cubero, Oswaldo Lorenzo‐Betancor, Carlos Cruchaga, Elena Lorenzo, Lluı́s Samaranch, María Cárcel, José Á. Obeso, María Rodríguez‐Oroz, Miquel Aguilar, F. Coria, María A. Pastor, Pau Pástor	3
13	Estudio de variantes de los genes BDNF, COMT, DAT1 y SERT en niños colombianos con déficit de atención 2016 ·Revista Colombiana de Psiquiatría ·(unknown), Carlos Bustos, Luis Carlos Morales, Bruno A. Benítez, (unknown), (unknown), Humberto Arboleda, (unknown)	4
14	Clinically early-stage CSPα mutation carrier exhibits remarkable terminal stage neuronal pathology with minimal evidence of synaptic loss 2015 ·Acta Neuropathologica Communications ·Bruno A. Benítez, Nigel J. Cairns, Robert E. Schmidt, John C. Morris, Joanne Norton, Carlos Cruchaga, Mark S. Sands	19
15	Pooled-DNA Sequencing for Elucidating New Genomic Risk Factors, Rare Variants Underlying Alzheimer’s Disease 2015 ·Methods in molecular biology ·Sheng Chih Jin, Bruno A. Benítez, Yuetiva Deming, Carlos Cruchaga	2
16	The TREM2 Variant p.R47H is a Risk Factor for Sporadic Amyotrophic Lateral Sclerosis (I5-2.002) 2014 ·Neurology ·Matthew Harms, Janet Cady, Erica Koval, Bruno A. Benítez, Craig M. Zaidman, Jennifer Jockel‐Balsarotti, Peggy Allred, Robert H. Baloh, John Ravits, Ericka Simpson, Stanley H. Appel, Alan Pestronk, Alison Goate, Timothy M. Miller, Carlos Cruchaga	1
17	The PSEN1, p.E318G Variant Increases the Risk of Alzheimer's Disease in APOE-ε4 Carriers 2013 ·PLoS Genetics ·Bruno A. Benítez, Celeste M. Karch, Yefei Cai, Sheng Chih Jin, Breanna Cooper, David Carrell, Sarah Bertelsen, Lori B. Chibnik, Julie A. Schneider, David Bennett, (unknown), Anne M. Fagan, David M. Holtzman, John C. Morris, Alison Goate, Carlos Cruchaga	52
18	TREM2 and Parkinson’s Disease 2013 ·New England Journal of Medicine ·Bruno A. Benítez, (unknown)	54
19	TREM2 is associated with the risk of Alzheimer's disease in Spanish population 2013 ·Neurobiology of Aging ·Bruno A. Benítez, Breanna Cooper, Pau Pástor, Sheng Chih Jin, Elena Lorenzo, Sebastián Cervantes, Carlos Cruchaga	118
20	Parkinson disease is not associated with C9ORF72 repeat expansions 2012 ·Neurobiology of Aging ·Matthew B. Harms, Drexel A. Neumann, Bruno A. Benítez, Breanna Cooper, David Carrell, Brad A. Racette, Joel S. Perlmutter, Alison Goate, Carlos Cruchaga	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact